| Members |
targetComponentId |
| generaliserad glesställning i underkäken |
Generalised spacing of mandibular teeth |
| generaliserad glesställning i överkäken |
Generalized spacing of maxillary teeth (finding) |
| Generic drug, hormone, vitamin AND/OR blood product |
Substance |
| Genotype |
Genetic finding |
| Genotype |
Genetic finding |
| Genotype |
Genetic finding |
| Genotypic expression |
Phenotype |
| gentamicin 0,3 %, ögondroppar |
Gentamicin sulfate 3 mg/mL eye solution |
| Gentamicin 0.3% eye drops |
Gentamicin sulfate 3 mg/mL eye solution |
| gentamicin 0,3 %, ögondroppar |
Gentamicin sulfate 3 mg/mL eye solution |
| Gentamicin 0.3% eye drops 10mL |
Gentamicin sulfate 3 mg/mL eye solution |
| Gentamicin 0.3% eye drops 10mL |
Gentamicin sulfate 3 mg/mL eye solution |
| Gentamicin 0.3% eye drops 5mL |
Gentamicin sulfate 3 mg/mL eye solution |
| Gentamicin 0.3% eye drops 5mL |
Gentamicin sulfate 3 mg/mL eye solution |
| gentamicin 0,3 %, ögondroppar utan konserveringsmedel |
Gentamicin sulfate 3 mg/mL eye solution |
| gentamicin 1 g, pulver till injektionsvätska, flaska |
Product containing only gentamicin in parenteral dose form (medicinal product form) |
| gentamicin 70 mg/100 ml, infusionsvätska, lösning |
Product containing only gentamicin in parenteral dose form (medicinal product form) |
| gentamicin 70 mg/100 ml, för infusion |
Product containing only gentamicin in parenteral dose form (medicinal product form) |
| gentamicin 90 mg/100 ml, infusionsvätska, lösning |
Product containing precisely gentamicin (as gentamicin sulfate) 900 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| gentamicin 90 mg/100 ml, för infusion |
Product containing precisely gentamicin (as gentamicin sulfate) 900 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| gentamicinsulfat 0,1 %, kräm |
Gentamicin (as gentamicin sulfate) 1 mg/mL cutaneous cream |
| gentamicinsulfat 0,1 %, salva |
Gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment |
| gentamicinsulfat 0,3 %, ögonsalva |
Gentamicin (as gentamicin sulfate) 3 mg/g eye ointment |
| gentamicinsulfat 1 %, kräm |
Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
| Gentamicin sulfate 3mg/g ointment |
Gentamicin (as gentamicin sulfate) 3 mg/g eye ointment |
| släktet Actinolea |
Genus Actinotalea (organism) |
| Genus Alopex |
Genus Vulpes (organism) |
| släktet alphaentomopox |
Genus Alphaentomopoxvirus |
| Genus Artictis |
Genus Arctictis (organism) |
| släktet Bizonia |
Genus Bizionia (organism) |
| Genus Casmerodius |
Genus Ardea (organism) |
| Genus Chiroptes |
Genus Chiropotes |
| släktet Chryseomonas |
Pseudomonas |
| Genus Cinnyricinlus |
Genus Cinnyricinclus (organism) |
| släktet coronavirus |
Subfamily Orthocoronavirinae (organism) |
| Genus Ebola-like viruses |
Genus Ebolavirus (organism) |
| släktet Flavimonas |
Pseudomonas |
| släktet Frangula |
Genus Rhamnus (organism) |
| Genus Hansenula |
Pichia |
| Genus Herpailurus |
Genus Puma (organism) |
| Genus Ictalurid herpes-like viruses |
Genus Ictalurivirus (organism) |
| Genus Infectious laryngo-tracheitis-like viruses |
Genus Iltovirus (organism) |
| Genus Marburg-like viruses |
Genus Marburgvirus (organism) |
| Genus Marek's disease-like viruses |
Genus Mardivirus (organism) |
| Genus Melanonycteris |
Genus Melonycteris |
| Genus Mungoticitis |
Genus Mungotictis |
| Genus Nesochen |
Branta |
| Genus Notornis |
Genus Porphyrio (organism) |
| Genus Oncifelis |
Genus Leopardus (organism) |
| Genus Otocolobus |
Genus Felis (organism) |
| Genus Parahyaena |
Genus Hyaena (organism) |
| släktet Pennisetum |
Genus Cenchrus (organism) |
| släktet picornavirus |
Family Picornaviridae (organism) |
| släktet Pseudobacillus |
Order Bacillales (organism) |
| Quadricoccus |
Genus Quatrionicoccus (organism) |
| släktet Salinococcus |
Genus Salinicoccus |
| Serpens |
Pseudomonas |
| Sulfophobococcus |
Genus Sulfophobococcus (organism) |
| Teichococcus |
Roseomonas |
| Geochelone elephantopus |
Geochelone nigra (organism) |
| Geochelone elongata |
Indotestudo elongata (organism) |
| Gerbich type |
Gerbich type |
| avböjt geriatrisk screening |
Geriatric screening declined (situation) |
| Geriatric screening refused |
Geriatric screening declined (situation) |
| Gianotti-Crosti syndrome |
Gianotti-Crosti syndrome |
| Giant |
Gigantism |
| Giant condyloma acuminatum |
Verrucous carcinoma |
| Gianturco-Roehm-filter |
Vena cava filter |
| gingival lamina dura, struktur |
Structure of lamina dura of tooth socket |
| prostatisk intraepitelial neoplasi, grad 3 |
High grade glandular intraepithelial neoplasia |
| glaukom orsakat av silikonolja |
Glaucoma caused by silicone oil |
| misstänkt glaukom |
Glaucoma suspect |
| Gliding bacteria |
Non-photosynthetic, non-fruiting gliding bacteria |
| glioblastom, kategori |
Glioblastoma |
| glioblastom |
Glioblastoma |
| glipizid 10 mg, tablett med modifierad frisättning |
Product containing only glipizide in oral dose form (medicinal product form) |
| glipizid 10 mg, depåtablett |
Product containing only glipizide in oral dose form (medicinal product form) |
| glipizid 2,5 mg, tablett med modifierad frisättning |
Product containing only glipizide in oral dose form (medicinal product form) |
| glipizid 2,5 mg, depåtablett |
Product containing only glipizide in oral dose form (medicinal product form) |
| glipizid 5 mg, tablett med modifierad frisättning |
Product containing only glipizide in oral dose form (medicinal product form) |
| glipizid 5 mg, depåtablett |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glucagonoma |
Glucagonoma (morphologic abnormality) |
| Gluconobacter oxydans subspecies industrius |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies melanogenes |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies oxydans |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies sphaericus |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies suboxydans |
Gluconobacter oxydans (organism) |
| glukos 10 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 15 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 20 %, infusionsvätska, lösning, polyetylenflaska 500 ml |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 20 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 40 %, infusionsvätska, lösning, flaska |
Glucose 400 mg/mL solution for injection |
| glukos 50 %, infusionsvätska, lösning, flaska |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 50 %, injektionsvätska, lösning, förfylld spruta |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glukos 70 %, infusionsvätska, lösning, påse |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Gluphosphate causing toxic effect |
Glyphosate toxicity |
| glycerin 10 %, ögondroppar |
Glycerol 10 mg/mL eye solution |
| glycerin 10 %, ögondroppar utan konserveringsmedel |
Glycerol 10 mg/mL eye solution |
| glycerin 20 %, ögondroppar |
Product containing only glycerol in ocular dose form (medicinal product form) |
| glycerin 20 %, ögondroppar utan konserveringsmedel |
Product containing only glycerol in ocular dose form (medicinal product form) |
| glycerin 30 %, ögondroppar |
Product containing only glycerol in ocular dose form (medicinal product form) |
FHIR